2019 Suggested Readings | European Society of Hypertension

Suggested Readings by Faculty

Prof. Enrico Agabiti Rosei

1. Assessment of Preclinical Organ Damage in Hypertension

2. Microvascular structure as a prognostically relevant endpoint

3. Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients

Prof. Michel Azizi

1. Drug induced hypertension -An unappreciated cause of secondary hypertension -main(1)

2. Adherence in Hypertension

3. Redfining diuretcis use in hypertension-why select a thiazide-like diuretic(8)

4. Drug adherence in hypertension-from methodological issues to cardiovascular outcomes(10)01

5. Secondary arterial hypertension-when,who,and how to screen(1)

6. Resistant hypertension-what the cardiologist needs to know(1)

7. Resistant hypertension-what the cardiologist needs to know(2)

8. Mineralocorticoid receptor antagonists

Prof. Claudio Borghi

1. The Epidemiology of Blood Pressure and Its Worldwide Management

2. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe-the EURIKA study

3. Hypertension in developing countries

4. Hypertension—A Public Health Challenge of Global Proportions

5. Hypertension in Women Recent Advances and Lingering Questions

6. The state of hypertension care in 44 low-income and middle-income countries – a cross-sectional study of nationally representative individual-level data from 1.1 million adults

7. Long term trend in awareness and treatemnt and control of BP across the world-Appendix-lancet 2019

8. Long-term and recent trends inhypertension awareness, treatment, and control in 12 high-income countries – an analysis of 123 nationally representative surveys

Prof. Jana Brguljan

1. Perioperative management of angiotensin-converting enzyme inhibitors and or angiotensin receptor blockers

2. Preoperative Hypertension

Prof. Renata Cifková

1. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

2. Author Queries

3. Predictive Value of the sFlt-1_PlGF Ratio in Women with Suspected Preeclampsia

Prof. Antonio Coca

1. High blood pressure, alzheimer disease and antihypertensive treatment

2. Blood pressure and cognitive performances in middle-aged adults

3. Effects of antihypertensive treatment on cognitive decline

4. Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly

Prof. Anna Dominiczak

1. 535 new loci associated with blood pressure traits

2. Recent Findings in the Genetics of Blood Pressure-How to Apply in Practice or is a Moonshot Required

Prof. Michael Doumas

1. 2018 ESC:ESH Guidelines for the management of arterial hypertension

2. Lifetime Risks of Cardiovascular Disease

3. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Diesease Risk Assessment

4. Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors US Preventive Services Task Force Recommendation Statement

Prof. Guido Grassi

1. The Sympathetic Nervous System Alterartions in Human Hypertension

2. Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates

3. Hypertension

Prof. Harris Grassos

1. Environmental Factors and Hypertension_link

2. Air Pollution And Arterial Hypertension. A New Risk Factor Is In the Air

Prof. Bojan Jelakovic

1. Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease

2. Effects of Intensive BP Control in CKD

3. EBRP Position Statement

4. Reconciling Results From ACCORD BP and SPRINT

5. Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy

6. Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid

7. Consensus statement on screening, diagnosis, classification and treatment of Endemic – Balkan – nephropathy

8. Aristolochic acid and the etiology of endemic – Balkan – nephropathy

Prof. Andrjez Januszewicz

1. Primary Aldosteronism and Obstructive Sleep Apnea-Is This A Bidirectional Relationship?

2. Cardiovascular Risk in Primary Hyperaldosteronism

3. How to Escape from Primary Aldosteronism? News and Views on an Adrenal Disorder of Salt Retention

4. The Clinical Phenotype of SDHC-Associated Hereditary Paraganglioma Syndrome (PGL3)

Dr. Alex Kasiakogias

1. Prevalence and management of systemic HTN in athletes

2. Athletes with Systemic Hypertension

3. Recommendations for competitive sports in arterial hypertension

Prof. Sverre Kjeldsen

1. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study LIFE

2. Randomised trial of effects of calcium antagonists compared with diuretics and B-blockers on cardiovascular morbidity and mortality in hypertns-NORDIL study

3. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine-Value trial

Prof. Vasilios Kotsis

1. Incident Left Ventricular Hypertrophy in Masked Hypertension

2. Masked hypertension-understanding its complexity

3. Target Organ Damage in White Coat Hypertension and Masked Hypertension

Prof. Reinhold Kreutz

1. Renin angiotensin in aldosterone inhibition in the treatment of cardiovascular disease

2. Strong and Sustained Antihypertensitve Effect of Small Interfering RNA Targeting Liver Angiotensinogen

Prof. Stéphane Laurent

1. The Structural Factor of Hypertension-Large and Small Artery Alterations

2. Concentp of Extremes in Vacular Aging-From Early Vascular Aging to Supernormal Vascular Aging

Prof. Dragan Lovic

Meetings/Events

Suggested Readings by Faculty